Platten, M., Schilling, D., Bunse, L., Wick, A., Bunse, T., Riehl, D., Green, E., Sanghvi, K., Karapanagiotou-Schenkel, I., Harting, I., Sahm, F., Steinbach, J., Weyerbrock, A., Hense, J., Misch, M., Krex, D., Stevanovic, S., Tabatabai, G., von Deimling, A., Schmitt, M., & Wick, W. (n.d.). aTIM-33. NOA-16: A FIRST-IN-MAN MULTICENTER PHASE I CLINICAL TRIAL OF THE GERMAN NEUROONCOLOGY WORKING GROUP EVALUATING A MUTATION-SPECIFIC PEPTIDE VACCINE TARGETING IDH1R132H IN PATIENTS WITH NEWLY DIAGNOSED MALIGNANT ASTROCYTOMAS. Neuro-oncology, 20, vi8–vi9. http://access.bl.uk/ark:/81055/vdc_100095200036.0x000017